References
- Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676.
- Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–1920.
- Lowry WE, Richter L, Yachechko R, et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci. 2008;105:2883–2888.
- Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872.
- Raab S, Klingenstein M, Liebau S, et al. A comparative view on human somatic cell sources for ipsc generation. Stem Cells Int. 2014;76:83–91.
- O'Connor MD, Kardel MD, Iosfina I, et al. Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells. 2008;26:1109–1116.
- Brambrink T, Foreman R, Welstead GG, et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell. 2008;2:151–149.
- Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotech. 2008;26:1276–1284.
- Chan EM, Ratanasirintrawoot S, Park IH, et al. Live cell imaging distinguishes bona fide human ips cells from partially reprogrammed cells. Nat Biotech. 2009;27:1033–1037.
- Dick E, Matsa E, Bispham J, et al. Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines. Stem Cell Res. 2011;6:158–167.
- Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature. 2009;460:49–52.
- Soldner F, Jaenisch R. IPSC disease modeling. Science. 2012;338:1155–1156.
- Scholer HR, Ruppert S, Suzuki N, et al. New type of pou domain in germ line-specific protein oct-4. Nature. 1990;344:435–439.
- Young Il Y, Ha H-S, Balling R, et al. Structure, expression and chromosomal location of the oct-4 gene. Mech Dev. 1991;35:171–179.
- Silva J, Nichols J, Theunissen TW, et al. Nanog is the gateway to the pluripotent ground state. Cell. 2009;138:722–737.
- Chambers I, Colby D, Robertson M, et al. Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113:643–655.
- Chen X, Xu H, Yuan P, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell. 2008;133:1106–1117.
- Mitsui K, Tokuzawa Y, Itoh H, et al. The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and es cells. Cell. 2003;113:631–642.
- Schwarz BA, Bar-Nur O, Silva JC, et al. Nanog is dispensable for the generation of induced pluripotent stem cells. Cur Biol. 2014;24:347–350.
- Alexander RE, Cheng L, Grignon DJ, et al. Cytoplasmic oct4 staining is a sensitive marker of neuroendocrine differentiation. Hum Pathol. 2014;45:27–32.
- Gu T-T, Liu S-Y, Zheng P-S. Cytoplasmic nanog-positive stromal cells promote human cervical cancer progression. Am J Pathol. 2012;181:652–661.
- Jeter CR, Badeaux M, Choy G, et al. Functional evidence that the self-renewal gene nanog regulates human tumor development. Stem Cells. 2009;27:993–1005.
- Oka M, Moriyama T, Asally M, et al. Differential role for transcription factor oct4 nucleocytoplasmic dynamics in somatic cell reprogramming and self-renewal of embryonic stem cells. J Biol Chem. 2013;288:15085–15097.
- Page RL, Ambady S, Holmes WF, et al. Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells. 2009;11:417–426.